Sharepoint Solutions
PRODUCTS
-
The TWIST™ Mini Liposome Extruder System is an all-inclusive modular liposome extrusion system. The intuitive design allows novice and expert users the ability to create liposome particles ranging from 50 nm to 10 um in diameter. With the heat block and extruder base, users have extended liposome creation capabilities and an easy, ergonomic set up. The TWIST™ System is the perfect solution for small scale R&D and liposome exploration projects.
-
Eurofins PSS Insourcing Solutions® (PSS) is a global, award-winning managed service provider that places our people at your site dedicated to running and managing your manufacturing and laboratory services while eliminating headcount, co-employment and project-management worries.
-
On-site labs with our own personnel offer greater control of samples and timelines, minimizing risk for our customers.
-
NOVA™ Software Upgrade Kit adds Enhanced Microfeed with programmable rates down to 5 µm/min, plus pop-up prompts and improved folder/program management.
-
Your trusted RTSM solution, PULSE is designed to support all study designs with configurable, pre-validated components. PULSE empowers study teams to easily manage randomization and trial supply workflows with flexibility and precision.
WHITE PAPERS AND CASE STUDIES
-
Advancing In Silico Predictions In Early Drug Discovery
Examine a high-throughput approach that streamlines LogD measurements, offering faster and more accurate insight into compound lipophilicity to support better decision-making in early drug discovery.
-
The Benefits Of End-To-End Formulation And Fill/Finish Of Biologics
Proper formulation development has a huge impact on whether a technology transfer to clinical phase fill/finish is successful. Review the challenges of transitioning a promising drug candidate.
-
eSource Purpose Is Not Just To Complete The EDC
Central eSource transforms data capture from a passive, back-end chore into an active, real-time quality and compliance engine—delivering benefits that extend beyond faster EDC feeds and reduced SDV.
-
Aseptic Filling Solution Enhances Sterility Assurance for Pharma Manufacturer
Emergent BioSolutions upgraded its Winnipeg site with the Cytiva SA25 aseptic filling workcell to improve sterility assurance, product flexibility, and regulatory compliance for CGT manufacturing.
-
Challenges And Solutions In Lyophilization Development For ADCs
Successful ADC lyophilization requires a robust, individualized process driven by thermal characterization using DSC and FDM to define the critical parameters for stability and efficient manufacturing.
-
Pioneering The End-To-End Decentralized Trial Experience
This collaboration highlights the potential of decentralized clinical trials (DCTs) to transform trial execution, as well as offering a replicable model for future research.
-
Best Practices For Harmonizing Global Data Disclosure
Learn how sponsors can address the challenge of submitting clinical trial data in a consistent and compliant manner by examining internal processes to identify and close gaps.
-
Rescuing A Global Program For NDA Success
Explore the collaboration that enabled FDA approval of a novel chronic-condition therapy, rescued a high-risk program, and demonstrated a unified “one-team” approach by reworking the sponsor's SAP.
-
How To Manage A Drug Product In A Medical Device Environment
Discover how ProPharma successfully ensured GMP and GDP compliance for a drug product within a medical device environment.
-
Partnering For Precision In An IPF Study: Securing Timely Deliverables And Key Endpoints
A pharmaceutical company enlisted Worldwide Clinical Trials to help achieve on-time results for their Phase IIa IPF clinical trial, enabling them to manage vendors and meet challenging deadlines.
-
Improving Patient Health And Safety
Engage an experienced CMC program management consultant to collaboratively develop and maintain a robust product development plan (PDP) with your team lead, cross-functional members, and vendors.
-
Advancing Dose Escalation Strategies With Bayesian Modeling
A CRO was engaged to help a biotechnology sponsor develop a novel oncology therapy design and execute a multicenter, open-label Phase 1/2 dose escalation and expansion study in advanced solid tumors.
NEWS
-
Coolbrook Achieves Breakthrough In Circular Materials: Large-Scale Pilot Successfully Cracks Plastic Waste Pyrolysis Oil9/15/2025
Coolbrook, a transformational technology and engineering company, has achieved a major breakthrough in circular plastics and materials by successfully cracking 100% plastic-waste-derived pyrolysis oil (py-oil) at its large-scale pilot facility using the RotoDynamic Reactor (RDR) technology.
-
Energy Department Slashes 47 Burdensome And Costly Regulations, Delivering First Milestone In America's Biggest Deregulatory Effort5/12/2025
The U.S. Department of Energy (DOE) today announced the first step in the Energy Department’s largest deregulatory effort in history, proposing the elimination or reduction of 47 regulations that are driving up costs and lowering quality of life for the American people.
-
Koh Young To Showcase Advanced Inspection At SEMICON Korea 20261/26/2026
Koh Young, the industry leader in True 3D measurement-based inspection and metrology solutions, will exhibit at SEMICON Korea 2026, held February 11–13, 2026 at COEX in Seoul.
-
Axim Biotechnologies Files Pre-Submission With FDA For CLIA Waiver Pathway On Lactoferrin Point-Of-Care Diagnostic Test6/24/2025
Axim Biotechnologies, Inc. a leading developer of rapid diagnostic testing for ocular and systemic conditions, today announced that it has filed a Pre-Submission (Pre-Sub Q) with the U.S. Food and Drug Administration (FDA) as the first formal step in seeking a Clinical Laboratory Improvement Amendments (CLIA) Waiver for its rapid, point-of-care Lactoferrin diagnostic test (TearScan Lf).
-
Safeguarding Citrus: International Collaboration Between Australia And Indonesia, Targets Huánglóngbìng Threat6/25/2025
NSW Department of Primary Industries and Regional Development (NSW DPIRD) has reaffirmed its commitment to protecting Australia’s citrus industry through international collaboration against huánglóngbìng (HLB), also known as citrus greening disease.